ReviewFrontiers in endocrinology2025
Parathyroid-independent hypercalcemia as initial presentation of renal sarcoidosis with granulomatous interstitial nephritis: a case report.
Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sarcoidosis is a multisystem granulomatous disorder predominantly affecting the lungs. Renal sarcoidosis often presents diagnostic challenges, PTH-independent hypercalcemia may be a clinical feature. Case Report: A 48-year-old Asian female presented with persistent hypercalcemia (2.81 mmol/L), suppressed Parathyroid hormone PTH(1.24 pg/mL), and renal dysfunction (serum creatinine 2.02 mg/dL). Initial imaging showed mediastinal lymphadenopathy, 1.biopsy could not be performed as the size and location of the lymph nodes precluded safe conduct of the procedure, but bone marrow puncture and PET/CT excluded malignancy. A renal biopsy performed three months later demonstrated focal multinucleated giant cells and calcium deposits-confirming renal sarcoidosis. She was initiated on methylprednisolone (16 mg/day), leading to normalized calcium levels and improved renal function (serum creatinine stabilized at 1.1 mg/dL). However, despite strictly following the treatment plan, she still underwent ureteroscopy lithotripsy due to recurrent episodes of nephrolithiasis. Long-term follow-up after drug discontinuation showed that the patient's calcium and PTH levels remained normal, while there was a mild impairment in renal function. Discussion: This case underscores the diagnostic difficulty of renal sarcoidosis, particularly in hypercalcemic patients without renal biopsy. Early use of corticosteroids can improve renal function, but complications like nephrolithiasis may still occur, so continuous monitoring is still necessary. A high index of suspicion and timely biopsy are essential for diagnosis and optimal management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.